Second Multiple Myeloma Antibody Approved – Empliciti | Cancer Biology
Frontiers | Understanding the Role of T-Cells in the Antimyeloma Effect of Immunomodulatory Drugs | Immunology
Mechanism of Action | EMPLICITI® (elotuzumab)
Elotuzumab: A Review in Relapsed and/or Refractory Multiple Myeloma | SpringerLink
Treatment of multiple myeloma with the immunostimulatory SLAMF7 antibody elotuzumab | Semantic Scholar
Elotuzumab Overview - Creative Biolabs
Monoclonal antibody treatment of Multiple Myeloma | Leaders in Pharmaceutical Business Intelligence (LPBI) Group
Elotuzumab: Uses, Interactions, Mechanism of Action | DrugBank Online
Second Multiple Myeloma Antibody Approved – Empliciti | Cancer Biology
elotuzumab: proposed mechanism of action in myeloma. Notes: (A) Direct... | Download Scientific Diagram
Frontiers | Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma | Immunology
Elotuzumab in the treatment of relapsed and refractory multiple myeloma | Future Oncology
Mechanisms of action of elotuzumab. The primary mechanism of action of... | Download Scientific Diagram
Frontiers | Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma | Immunology
Daratumumab, Elotuzumab, and the Development of Therapeutic Monoclonal Antibodies in Multiple Myeloma - Laubach - 2017 - Clinical Pharmacology & Therapeutics - Wiley Online Library
Cancers | Free Full-Text | Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma | HTML
Spotlight on elotuzumab in the treatment of multiple myeloma: the evid | OTT
Current use of monoclonal antibodies in the treatment of multiple myeloma - Varga - 2018 - British Journal of Haematology - Wiley Online Library
The mechanisms of action of elotuzumab. Upper left, elotuzumab binds... | Download Scientific Diagram
Mechanism of action of anti-CS1 antibody (elotuzumab) against multiple... | Download Scientific Diagram
Frontiers | Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma | Oncology
OncoPrescribe - Write The Perfect Prescription
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) | Leukemia
